Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
16 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05931302 | Initial Staging of Lobular Breast Carcinoma: Head to Head Comparison of 68Ga-FAPI-46 and 18F-FDG PET/CT(GALILEE) | active not recruiting | N/A | 40 | Centre Hospitalier Intercommunal de Toulon La Seyne sur MerOTHER | 1 | Jul 7, 2026 | clinicaltrials |
| NCT04616846 | Thromboembolic Risk Screening in Patients With Cancer and COVID-19(NEOTHROCOVID) | completed | N/A | 88 | Centre Antoine LacassagneOTHER |
| 2 |
| Jul 1, 2026 |
| clinicaltrials |
| NCT06660147 | Validation of KELIM as a Predictive/Prognostic Factor for Maintenance Treatment With iPARP in First-Line Ovarian Cancer(KELI-PAOLA) | completed | — | 243 | ARCAGY/ GINECO GROUPOTHER | 2 | Jun 23, 2026 | clinicaltrials |
| NCT04198727 | Study of the Impact of DPD Activity on the Efficacy of Capecitabine(DPDMAX) | active not recruiting | Phase 2 | 155 | Centre Antoine LacassagneOTHER | 2 | Jun 2, 2026 | clinicaltrials |
| NCT03774732 | PD-1 Inhibitor and Chemotherapy With Concurrent Irradiation at Varied Tumour Sites in Advanced Non-small Cell Lung Cancer(NIRVANA-LUNG) | active not recruiting | Phase 3 | 327 | UNICANCEROTHER | 2 | Feb 25, 2026 | clinicaltrials |
| NCT03467360 | Phase I Trial of CArbonic Anhydrase Inhibition in Combination With Radiochemotherapy or Radioimmunotherapy in Small Cell Lung Carcinoma(ICAR) | recruiting | Phase 1 | 27 | Centre Antoine LacassagneOTHER | 2 | Jan 20, 2026 | clinicaltrials |
| NCT01210274 | Characterization of the Mechanisms of Resistance to Azacitidine | recruiting | — | 250 | Centre Hospitalier Universitaire de NiceOTHER | 2 | Mar 19, 2025 | clinicaltrials |
| NCT04015804 | Robotic Low Rectum Anterior Resection(GROG-R01) | completed | N/A | 833 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 3 | Feb 12, 2025 | clinicaltrials |
| NCT04144387 | Evaluation of the Impact of the Update SMM Criteria on the Natural History of SMM to Establish New Recommendations.(CARRISMM) | active not recruiting | N/A | 395 | Intergroupe Francophone du MyelomeNETWORK | 3 | Mar 6, 2024 | clinicaltrials |
| NCT01864850 | Non Inferiority Trial of Standard RT Versus Hypofractionated Split Course in Elderly Vulnerable Patients With HNSCC(ELAN-RT) | completed | Phase 3 | 202 | Groupe Oncologie Radiotherapie Tete et CouOTHER | 2 | Sep 22, 2023 | clinicaltrials |
| NCT04385433 | A Comparative Study of Pravastatin vs Placebo as Primary Prevention of Severe Subcutaneous Breast Fibrosis in Hyper-radiosensitive Identified Patients With Breast Cancer(PRAVAPREV-01) | terminated | Phase 3 | 15 | Institut du Cancer de Montpellier - Val d'AurelleOTHER | 2 | Aug 24, 2023 | clinicaltrials |
| NCT01802749 | Bevacizumab Beyond Progression in Platinum Sensitive Ovarian Cancer(MITO16MANGO2b) | unknown | Phase 3 | 406 | National Cancer Institute, NaplesOTHER | 5 | Mar 24, 2023 | clinicaltrials |
| NCT02477644 | Platine, Avastin and OLAparib in 1st Line(PAOLA-1) | completed | Phase 3 | 806 | Arcagy ResearchOTHER | 11 | Aug 2, 2022 | clinicaltrials |
| NCT01183832 | Radiotherapy - Anastrazole Concomitant : Evaluation of the Side Effects(ORACLES) | completed | — | 490 | Centre Oscar LambretOTHER | 2 | May 30, 2019 | clinicaltrials |
| NCT00930410 | Intra-ductal Confocal Endomicroscopy for Characterization of Pancreas and Bile Duct Tumor(EMID) | completed | N/A | 50 | Institut Paoli-CalmettesOTHER | 2 | Mar 20, 2013 | clinicaltrials |
| NCT00006118 | Cisplatin, Paclitaxel, and Gemcitabine in Treating Patients With Progressive Unresectable Regional or Metastatic Bladder Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 2 | Jul 24, 2008 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials